Skip to content
MedsAcross

Medicine

Enalapril 5 mg tablet

Enalapril · Oral
Available on requestPrescription onlyUS FDAGeneric name

Enalapril 5 mg tablet is a generic prescription medicine for oral use, made by 18 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F)…

Key facts

Active ingredient (INN)
Enalapril
Brand
Sold under the generic name
Strength
5 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 1000 tablets, 500 tablets and 66 more
Manufacturers
Avet PharmaceuticalsIndiaSun Pharmaceutical IndustriesIndiaA-S Medication SolutionsBryant Ranch PrepackSolco HealthcareAmici PharmaOceanside PharmaceuticalsRising Pharma HoldingsScieGen PharmaceuticalsChartwell RX18 labelers on the register
Origin register
US FDA, United States
Storage
Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F). Protect from moisture.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
C09AA02 Enalapril
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
24 December 1985
Identifiers
RxCUI 858804, 858810, 858813 +1DailyMed set ID 71e9fff3-7283-437e-b107-72fc16f09989, 0c829189-fba2-48f8-a23f-d5471a0345f6, 0ad4bfb4-62db-4759-af60-88eb031d125a +22NDC 64980-686, 43547-546, 50090-3378 +22Application ANDA218531, ANDA213273, ANDA075657 +5

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

A sample of 40 packs from 18 labelers. The register lists 69 packs for this generic presentation, and we confirm the exact pack on the quote.

PackCodeLabelerMarketed since
100 tablet in 1 bottle23155-705-01Avet PharmaceuticalsIndia28 April 2020
1000 tablet in 1 bottle23155-705-10Avet PharmaceuticalsIndia28 April 2020
100 tablet in 1 bottle51672-4038-1Sun Pharmaceutical IndustriesIndia23 January 2001
1000 tablet in 1 bottle51672-4038-3Sun Pharmaceutical IndustriesIndia23 January 2001
100 tablet in 1 bottle69292-542-01Amici Pharma15 October 2025
1000 tablet in 1 bottle69292-542-10Amici Pharma15 October 2025
500 tablet in 1 bottle69292-542-50Amici Pharma5 September 2026
90 tablet in 1 bottle62135-590-90Chartwell RX27 April 2023
90 tablet in 1 bottle68645-605-90Legacy Pharmaceutical Packaging14 November 2022
100 tablet in 1 bottle68682-711-01Oceanside Pharmaceuticals24 December 1985
1000 tablet in 1 bottle68682-711-10Oceanside Pharmaceuticals24 December 1985
100 tablet in 1 bottle64980-686-01Rising Pharma Holdings24 February 2025
1000 tablet in 1 bottle64980-686-10Rising Pharma Holdings24 February 2025
100 tablet in 1 bottle50228-229-01ScieGen Pharmaceuticals12 February 2025
1000 tablet in 1 bottle50228-229-10ScieGen Pharmaceuticals12 February 2025
30 tablet in 1 bottle43547-546-03Solco Healthcare31 July 2022
90 tablet in 1 bottle43547-546-09Solco Healthcare31 July 2022
100 tablet in 1 bottle43547-546-10Solco Healthcare31 July 2022
1000 tablet in 1 bottle43547-546-11Solco Healthcare31 July 2022
500 tablet in 1 bottle43547-546-50Solco Healthcare31 July 2022
30 tablet in 1 bottle, plastic50090-3378-0A-S Medication Solutions28 November 2014
100 tablet in 1 bottle50090-3378-1A-S Medication Solutions22 February 2018
90 tablet in 1 bottle50090-3378-3A-S Medication Solutions19 November 2022
30 tablet in 1 bottle50090-6490-0A-S Medication Solutions18 May 2023
100 tablet in 1 bottle50090-6490-1A-S Medication Solutions18 May 2023
90 tablet in 1 bottle50090-6490-3A-S Medication Solutions18 May 2023
30 tablet in 1 bottle50090-7222-0A-S Medication Solutions13 August 2024
100 tablet in 1 bottle50090-7222-1A-S Medication Solutions13 August 2024
90 tablet in 1 bottle50090-7222-3A-S Medication Solutions13 August 2024
30 tablet in 1 bottle50090-7302-0A-S Medication Solutions14 October 2024
100 tablet in 1 bottle50090-7302-1A-S Medication Solutions14 October 2024
90 tablet in 1 bottle50090-7302-3A-S Medication Solutions14 October 2024
30 tablet in 1 bottle50090-8131-0A-S Medication Solutions8 October 2026
100 tablet in 1 bottle50090-8131-1A-S Medication Solutions8 October 2026
90 tablet in 1 bottle50090-8131-3A-S Medication Solutions8 October 2026
150 tablet in 1 bottle71335-1910-1Bryant Ranch Prepack20 August 2026
100 tablet in 1 bottle71335-1910-2Bryant Ranch Prepack27 October 2023
30 tablet in 1 bottle71335-1910-3Bryant Ranch Prepack17 September 2021
60 tablet in 1 bottle71335-1910-4Bryant Ranch Prepack20 August 2026
90 tablet in 1 bottle71335-1910-5Bryant Ranch Prepack11 August 2021

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 24 December 1985Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Enalapril 5 mg tablet.

Compare 1

Other strengths and forms of Enalapril

Clinical summary

Enalapril is an angiotensin converting enzyme inhibitor indicated for the treatment of hypertension. It is available as tablets and oral solution. MedsAcross supplies Enalapril for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Enalapril

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Enalapril 5 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.